Luis Velazquez Ruisanchez
Hematology & Oncology · San Juan, PRNPI 1811557523
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.7% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,050, more than ten times the $56 reported in 2022. That places this record below the midpoint for hematology & oncology clinicians in PR, where the typical reported total is $10,882.
Across 97 payments — averaging $27.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$454
- Genentech USA, Inc.$294
- Sobi, Inc$262
- E.r. Squibb & Sons, L.L.C.$176
- AstraZeneca$171
- Amgen$171
- plus $1K from 18 others
What the payments were for
- Food & beverage$2,49794%
- Education$1696%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $454 |
| Genentech USA, Inc. | 16 | $294 |
| Sobi, Inc | 9 | $262 |
| E.r. Squibb & Sons, L.L.C. | 4 | $176 |
| AstraZeneca | 5 | $171 |
| Amgen | 3 | $171 |
| Johnson & Johnson | 6 | $145 |
| Eisai Inc. | 1 | $110 |
| Merck | 4 | $98 |
| PBG Puerto Rico LLC | 4 | $84 |
| Novartis | 3 | $83 |
| Astellas Pharma US Inc | 1 | $78 |
| Caris MPI, Inc. | 3 | $72 |
| Exelixis Inc. | 4 | $70 |
| Lilly USA, LLC | 1 | $58 |
| Boehringer Ingelheim | 2 | $57 |
| Sanofi | 3 | $55 |
| Incyte Corporation | 2 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| Deciphera Pharmaceuticals Inc. | 2 | $38 |
| Verity Pharmaceuticals Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Adaptive Biotechnologies Corporation | 1 | $20 |
| Bayer Puerto Rico Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IMDELLTRA (AMG 757)$125
- Venclexta$125
- Reblozyl$114
- LENVIMA$110
How this compares
$2,666 in reported general payments places this provider in the 20th percentile of 138 hematology & oncology providers in Puerto Rico.
Other hematology & oncology in San Juan
- Alexis Cruz ChaconSan Juan$450K
- Jose Lozada CostasSan Juan$260K
- Cristian Rodriguez ArochoSan Juan$227K
- Noridza Rivera RodriguezSan Juan$177K
- Mirelis AcostaSan Juan$154K
- Luis Baez VallecilloSan Juan$107K
- Edgardo Santiago-GuzmanSan Juan$79K
- Adelba Torres-LopezSan Juan$73K
- Karla Feliciano SalvaSan Juan$44K
- Luis Delgado MateuSan Juan$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.